nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR1A—Parkinson's disease	0.318	0.414	CbGaD
Ondansetron—CYP2E1—Parkinson's disease	0.26	0.338	CbGaD
Ondansetron—CYP2D6—Parkinson's disease	0.191	0.248	CbGaD
Ondansetron—HTR3A—enteric nervous system—Parkinson's disease	0.0137	0.155	CbGeAlD
Ondansetron—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0104	0.118	CbGeAlD
Ondansetron—Alosetron—CYP2E1—Parkinson's disease	0.00471	1	CrCbGaD
Ondansetron—OPRM1—telencephalic ventricle—Parkinson's disease	0.00393	0.0446	CbGeAlD
Ondansetron—HTR1B—telencephalic ventricle—Parkinson's disease	0.0036	0.0408	CbGeAlD
Ondansetron—HTR1A—telencephalic ventricle—Parkinson's disease	0.0029	0.0329	CbGeAlD
Ondansetron—HTR3A—nerve—Parkinson's disease	0.0027	0.0307	CbGeAlD
Ondansetron—OPRM1—nerve—Parkinson's disease	0.00248	0.0281	CbGeAlD
Ondansetron—SLC47A1—hindbrain—Parkinson's disease	0.00199	0.0226	CbGeAlD
Ondansetron—SLC47A2—head—Parkinson's disease	0.0018	0.0204	CbGeAlD
Ondansetron—HTR4—brain—Parkinson's disease	0.00172	0.0195	CbGeAlD
Ondansetron—SLC47A2—nervous system—Parkinson's disease	0.00171	0.0194	CbGeAlD
Ondansetron—SLC47A2—central nervous system—Parkinson's disease	0.00164	0.0186	CbGeAlD
Ondansetron—HTR1A—hindbrain—Parkinson's disease	0.00137	0.0155	CbGeAlD
Ondansetron—SLC47A2—brain—Parkinson's disease	0.0013	0.0148	CbGeAlD
Ondansetron—HTR3A—brainstem—Parkinson's disease	0.00116	0.0132	CbGeAlD
Ondansetron—SLC47A1—brainstem—Parkinson's disease	0.00114	0.0129	CbGeAlD
Ondansetron—HTR3A—forebrain—Parkinson's disease	0.00112	0.0127	CbGeAlD
Ondansetron—OPRM1—brainstem—Parkinson's disease	0.00106	0.0121	CbGeAlD
Ondansetron—OPRM1—forebrain—Parkinson's disease	0.00103	0.0116	CbGeAlD
Ondansetron—HTR1B—brainstem—Parkinson's disease	0.000974	0.011	CbGeAlD
Ondansetron—HTR1B—forebrain—Parkinson's disease	0.00094	0.0107	CbGeAlD
Ondansetron—SLC47A1—medulla oblongata—Parkinson's disease	0.000795	0.00902	CbGeAlD
Ondansetron—HTR1B—cardiovascular system—Parkinson's disease	0.000795	0.00901	CbGeAlD
Ondansetron—HTR1A—brainstem—Parkinson's disease	0.000786	0.00891	CbGeAlD
Ondansetron—HTR1A—forebrain—Parkinson's disease	0.000758	0.0086	CbGeAlD
Ondansetron—CYP2D6—hindbrain—Parkinson's disease	0.000744	0.00844	CbGeAlD
Ondansetron—SLC47A1—spinal cord—Parkinson's disease	0.000709	0.00804	CbGeAlD
Ondansetron—OPRM1—midbrain—Parkinson's disease	0.000678	0.00769	CbGeAlD
Ondansetron—KCNH2—forebrain—Parkinson's disease	0.000675	0.00766	CbGeAlD
Ondansetron—OPRM1—spinal cord—Parkinson's disease	0.000662	0.0075	CbGeAlD
Ondansetron—HTR3A—head—Parkinson's disease	0.000641	0.00727	CbGeAlD
Ondansetron—HTR1A—cardiovascular system—Parkinson's disease	0.000641	0.00727	CbGeAlD
Ondansetron—SLC47A1—head—Parkinson's disease	0.00063	0.00714	CbGeAlD
Ondansetron—HTR1B—midbrain—Parkinson's disease	0.00062	0.00704	CbGeAlD
Ondansetron—HTR3A—nervous system—Parkinson's disease	0.000608	0.0069	CbGeAlD
Ondansetron—HTR1B—spinal cord—Parkinson's disease	0.000605	0.00687	CbGeAlD
Ondansetron—SLC47A1—nervous system—Parkinson's disease	0.000597	0.00677	CbGeAlD
Ondansetron—OPRM1—head—Parkinson's disease	0.000588	0.00667	CbGeAlD
Ondansetron—HTR3A—central nervous system—Parkinson's disease	0.000585	0.00664	CbGeAlD
Ondansetron—SLC47A1—central nervous system—Parkinson's disease	0.000575	0.00652	CbGeAlD
Ondansetron—KCNH2—cardiovascular system—Parkinson's disease	0.000571	0.00647	CbGeAlD
Ondansetron—SLC47A1—cerebellum—Parkinson's disease	0.000562	0.00637	CbGeAlD
Ondansetron—OPRM1—nervous system—Parkinson's disease	0.000557	0.00632	CbGeAlD
Ondansetron—HTR1B—head—Parkinson's disease	0.000538	0.0061	CbGeAlD
Ondansetron—OPRM1—central nervous system—Parkinson's disease	0.000537	0.00609	CbGeAlD
Ondansetron—HTR1B—nervous system—Parkinson's disease	0.00051	0.00578	CbGeAlD
Ondansetron—HTR1A—midbrain—Parkinson's disease	0.000501	0.00568	CbGeAlD
Ondansetron—HTR1B—central nervous system—Parkinson's disease	0.000491	0.00557	CbGeAlD
Ondansetron—HTR1A—spinal cord—Parkinson's disease	0.000489	0.00554	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—Parkinson's disease	0.000488	0.00553	CbGeAlD
Ondansetron—HTR3A—brain—Parkinson's disease	0.000465	0.00527	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—Parkinson's disease	0.000464	0.00526	CbGeAlD
Ondansetron—SLC47A1—brain—Parkinson's disease	0.000457	0.00518	CbGeAlD
Ondansetron—KCNH2—midbrain—Parkinson's disease	0.000446	0.00506	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—Parkinson's disease	0.00044	0.00499	CbGeAlD
Ondansetron—KCNH2—spinal cord—Parkinson's disease	0.000435	0.00493	CbGeAlD
Ondansetron—HTR1A—head—Parkinson's disease	0.000434	0.00492	CbGeAlD
Ondansetron—CYP2D6—brainstem—Parkinson's disease	0.000427	0.00484	CbGeAlD
Ondansetron—OPRM1—brain—Parkinson's disease	0.000426	0.00483	CbGeAlD
Ondansetron—CYP2D6—forebrain—Parkinson's disease	0.000412	0.00467	CbGeAlD
Ondansetron—HTR1A—nervous system—Parkinson's disease	0.000412	0.00467	CbGeAlD
Ondansetron—HTR1A—central nervous system—Parkinson's disease	0.000396	0.00449	CbGeAlD
Ondansetron—HTR1B—brain—Parkinson's disease	0.00039	0.00442	CbGeAlD
Ondansetron—HTR1A—cerebellum—Parkinson's disease	0.000387	0.00439	CbGeAlD
Ondansetron—KCNH2—head—Parkinson's disease	0.000387	0.00438	CbGeAlD
Ondansetron—CYP2E1—medulla oblongata—Parkinson's disease	0.000376	0.00426	CbGeAlD
Ondansetron—KCNH2—nervous system—Parkinson's disease	0.000366	0.00416	CbGeAlD
Ondansetron—KCNH2—central nervous system—Parkinson's disease	0.000353	0.004	CbGeAlD
Ondansetron—KCNH2—cerebellum—Parkinson's disease	0.000345	0.00391	CbGeAlD
Ondansetron—CYP2E1—spinal cord—Parkinson's disease	0.000335	0.0038	CbGeAlD
Ondansetron—HTR1A—brain—Parkinson's disease	0.000315	0.00357	CbGeAlD
Ondansetron—CYP2E1—head—Parkinson's disease	0.000298	0.00338	CbGeAlD
Ondansetron—CYP2E1—nervous system—Parkinson's disease	0.000282	0.0032	CbGeAlD
Ondansetron—KCNH2—brain—Parkinson's disease	0.00028	0.00318	CbGeAlD
Ondansetron—CYP2E1—central nervous system—Parkinson's disease	0.000272	0.00308	CbGeAlD
Ondansetron—CYP2E1—cerebellum—Parkinson's disease	0.000266	0.00301	CbGeAlD
Ondansetron—CYP2D6—head—Parkinson's disease	0.000236	0.00267	CbGeAlD
Ondansetron—CYP3A4—nervous system—Parkinson's disease	0.000227	0.00258	CbGeAlD
Ondansetron—CYP2D6—nervous system—Parkinson's disease	0.000223	0.00253	CbGeAlD
Ondansetron—CYP3A4—central nervous system—Parkinson's disease	0.000219	0.00248	CbGeAlD
Ondansetron—CYP2E1—brain—Parkinson's disease	0.000216	0.00245	CbGeAlD
Ondansetron—CYP2D6—central nervous system—Parkinson's disease	0.000215	0.00244	CbGeAlD
Ondansetron—CYP2D6—cerebellum—Parkinson's disease	0.00021	0.00238	CbGeAlD
Ondansetron—CYP2D6—brain—Parkinson's disease	0.000171	0.00194	CbGeAlD
Ondansetron—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.44e-05	0.000178	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—INS—Parkinson's disease	2.44e-05	0.000178	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	2.42e-05	0.000176	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	2.41e-05	0.000175	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.39e-05	0.000174	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.39e-05	0.000174	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MCCC1—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ND3—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GCH1—Parkinson's disease	2.37e-05	0.000172	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.36e-05	0.000172	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.36e-05	0.000172	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—INSR—Parkinson's disease	2.31e-05	0.000168	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	2.27e-05	0.000166	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.26e-05	0.000165	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.24e-05	0.000163	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—OMD—Parkinson's disease	2.24e-05	0.000163	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.24e-05	0.000163	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	2.2e-05	0.000161	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—DDC—Parkinson's disease	2.2e-05	0.00016	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—DDC—Parkinson's disease	2.2e-05	0.00016	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	2.19e-05	0.00016	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGB—Parkinson's disease	2.18e-05	0.000159	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.17e-05	0.000158	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	2.17e-05	0.000158	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GBA—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—DBH—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.12e-05	0.000154	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—DBH—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GBA—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.08e-05	0.000152	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.08e-05	0.000151	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTA4—Parkinson's disease	2.07e-05	0.000151	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—INSR—Parkinson's disease	2.03e-05	0.000148	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	2.03e-05	0.000148	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.02e-05	0.000147	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	1.96e-05	0.000143	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGB—Parkinson's disease	1.92e-05	0.00014	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.92e-05	0.00014	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.91e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.9e-05	0.000139	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	1.9e-05	0.000138	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.89e-05	0.000138	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.89e-05	0.000138	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	1.88e-05	0.000137	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CTGF—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.85e-05	0.000135	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MAOB—Parkinson's disease	1.85e-05	0.000135	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	1.85e-05	0.000135	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ND3—Parkinson's disease	1.84e-05	0.000134	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.84e-05	0.000134	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	1.83e-05	0.000134	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	1.83e-05	0.000134	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.82e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.82e-05	0.000133	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CASP3—Parkinson's disease	1.82e-05	0.000132	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—Parkinson's disease	1.81e-05	0.000132	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.8e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GBA—Parkinson's disease	1.8e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—DBH—Parkinson's disease	1.8e-05	0.000131	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	1.79e-05	0.00013	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.76e-05	0.000128	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	1.74e-05	0.000127	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—OMD—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—NQO1—Parkinson's disease	1.72e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—TH—Parkinson's disease	1.69e-05	0.000123	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	1.67e-05	0.000122	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MAPK8—Parkinson's disease	1.67e-05	0.000122	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.66e-05	0.000121	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.66e-05	0.000121	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.64e-05	0.000119	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYCS—Parkinson's disease	1.63e-05	0.000118	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.63e-05	0.000118	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	1.62e-05	0.000118	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	1.62e-05	0.000118	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.59e-05	0.000116	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—DDC—Parkinson's disease	1.56e-05	0.000114	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.56e-05	0.000114	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—DDC—Parkinson's disease	1.55e-05	0.000113	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.54e-05	0.000112	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.54e-05	0.000112	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.47e-05	0.000107	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.47e-05	0.000107	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.46e-05	0.000106	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.44e-05	0.000105	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.44e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—COMT—Parkinson's disease	1.44e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GSTP1—Parkinson's disease	1.43e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MAOA—Parkinson's disease	1.43e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—HMOX1—Parkinson's disease	1.41e-05	0.000103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.4e-05	0.000102	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.4e-05	0.000102	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GBA—Parkinson's disease	1.39e-05	0.000101	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.39e-05	0.000101	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DBH—Parkinson's disease	1.39e-05	0.000101	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.38e-05	0.0001	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	1.37e-05	0.0001	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ABCB1—Parkinson's disease	1.36e-05	9.88e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	1.36e-05	9.88e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.35e-05	9.84e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.35e-05	9.82e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CTGF—Parkinson's disease	1.35e-05	9.82e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.33e-05	9.67e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—DDC—Parkinson's disease	1.32e-05	9.63e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GSTM1—Parkinson's disease	1.32e-05	9.59e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	9.59e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.31e-05	9.57e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.31e-05	9.55e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.3e-05	9.49e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	1.3e-05	9.44e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.28e-05	9.35e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.26e-05	9.19e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.26e-05	9.15e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.25e-05	9.1e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.25e-05	9.07e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.24e-05	9.05e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.24e-05	9.03e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.23e-05	8.98e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TH—Parkinson's disease	1.23e-05	8.94e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TH—Parkinson's disease	1.22e-05	8.92e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.19e-05	8.69e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGF—Parkinson's disease	1.19e-05	8.67e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.18e-05	8.58e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.18e-05	8.56e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.17e-05	8.52e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.16e-05	8.48e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.13e-05	8.25e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.13e-05	8.24e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.12e-05	8.19e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.12e-05	8.14e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.11e-05	8.11e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—APOE—Parkinson's disease	1.08e-05	7.89e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—Parkinson's disease	1.07e-05	7.77e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.06e-05	7.72e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APOE—Parkinson's disease	1.05e-05	7.67e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—COMT—Parkinson's disease	1.04e-05	7.6e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—COMT—Parkinson's disease	1.04e-05	7.58e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.04e-05	7.56e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.04e-05	7.55e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.04e-05	7.54e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.03e-05	7.53e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.03e-05	7.48e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.02e-05	7.46e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.02e-05	7.44e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DDC—Parkinson's disease	1.02e-05	7.43e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—INS—Parkinson's disease	1.02e-05	7.43e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ABCB1—Parkinson's disease	9.83e-06	7.16e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ABCB1—Parkinson's disease	9.81e-06	7.14e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	9.78e-06	7.12e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	9.68e-06	7.05e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.64e-06	7.02e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CTGF—Parkinson's disease	9.59e-06	6.98e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTM1—Parkinson's disease	9.54e-06	6.95e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTM1—Parkinson's disease	9.52e-06	6.93e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CTGF—Parkinson's disease	9.51e-06	6.92e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—INS—Parkinson's disease	9.26e-06	6.74e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GPX1—Parkinson's disease	9.14e-06	6.65e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GPX1—Parkinson's disease	9.12e-06	6.64e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APOE—Parkinson's disease	9.1e-06	6.62e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—INS—Parkinson's disease	9e-06	6.56e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.93e-06	6.51e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	8.86e-06	6.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.83e-06	6.43e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NQO1—Parkinson's disease	8.76e-06	6.38e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TH—Parkinson's disease	8.71e-06	6.34e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.68e-06	6.32e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TH—Parkinson's disease	8.63e-06	6.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.59e-06	6.26e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTHFR—Parkinson's disease	8.43e-06	6.14e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTHFR—Parkinson's disease	8.42e-06	6.13e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYCS—Parkinson's disease	8.36e-06	6.09e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYCS—Parkinson's disease	8.29e-06	6.03e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	8.28e-06	6.03e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CTGF—Parkinson's disease	8.12e-06	5.92e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—Parkinson's disease	7.85e-06	5.72e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—Parkinson's disease	7.83e-06	5.71e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INS—Parkinson's disease	7.77e-06	5.66e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	7.59e-06	5.53e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	7.57e-06	5.51e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	7.55e-06	5.49e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NQO1—Parkinson's disease	7.48e-06	5.45e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—COMT—Parkinson's disease	7.4e-06	5.39e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TH—Parkinson's disease	7.38e-06	5.37e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.37e-06	5.37e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.35e-06	5.35e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—COMT—Parkinson's disease	7.34e-06	5.34e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTP1—Parkinson's disease	7.3e-06	5.32e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MAOA—Parkinson's disease	7.29e-06	5.31e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.27e-06	5.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—Parkinson's disease	7.2e-06	5.25e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYCS—Parkinson's disease	7.08e-06	5.16e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	6.98e-06	5.08e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.98e-06	5.08e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCB1—Parkinson's disease	6.91e-06	5.04e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.77e-06	4.93e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6.71e-06	4.89e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—INS—Parkinson's disease	6.71e-06	4.88e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	6.7e-06	4.88e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—INS—Parkinson's disease	6.69e-06	4.87e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	6.66e-06	4.85e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.48e-06	4.72e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—Parkinson's disease	6.43e-06	4.68e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.39e-06	4.65e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—COMT—Parkinson's disease	6.27e-06	4.57e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.27e-06	4.57e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTP1—Parkinson's disease	6.24e-06	4.55e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MAOA—Parkinson's disease	6.23e-06	4.53e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	6.16e-06	4.49e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—Parkinson's disease	6.16e-06	4.48e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.98e-06	4.36e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—Parkinson's disease	5.93e-06	4.32e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.91e-06	4.3e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.84e-06	4.25e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	5.79e-06	4.21e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.78e-06	4.21e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	5.75e-06	4.19e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.74e-06	4.18e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TH—Parkinson's disease	5.69e-06	4.15e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—Parkinson's disease	5.57e-06	4.06e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—Parkinson's disease	5.52e-06	4.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.49e-06	4e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.47e-06	3.98e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	5.32e-06	3.87e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—Parkinson's disease	5.07e-06	3.69e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—COMT—Parkinson's disease	4.84e-06	3.52e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.82e-06	3.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.81e-06	3.5e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—INS—Parkinson's disease	4.76e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.75e-06	3.46e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—Parkinson's disease	4.72e-06	3.44e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—INS—Parkinson's disease	4.72e-06	3.44e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.56e-06	3.32e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—Parkinson's disease	4.46e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.43e-06	3.22e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.24e-06	3.09e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—INS—Parkinson's disease	4.03e-06	2.94e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—Parkinson's disease	3.93e-06	2.86e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.91e-06	2.85e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—Parkinson's disease	3.64e-06	2.65e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—Parkinson's disease	3.4e-06	2.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—INS—Parkinson's disease	3.11e-06	2.27e-05	CbGpPWpGaD
